MedTrace Logo

Improving Patient Prioritization During Hospital-homecare Transition

NCT04136951 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1915

Last updated 2025-10-08

Study results available
· View outcomes & findings →

Summary

This research work is focused on building and evaluating one of the first evidence-based clinical decision support tools for homecare in the United States. The results of this study have the potential to standardize and individualize nursing decision making using cutting-edge technology and to improve patient outcomes in the homecare setting.

Conditions

  • Diabetes Mellitus, Type 2
  • Congestive Heart Failure
  • Obstructive Pulmonary Disease
  • Dyspnea
  • Renal Failure

Interventions

OTHER

PREVENT clinical decision support

PREVENT clinical decision support tool consideres five patient risk factors as significant predictors of patient's priority for the first homecare nursing visit: (a) Presence of wounds (either surgical or pressure ulcers); (b) a documented comorbid condition of depression; (c) need for assistive equipment, assistive person, or both for toileting; (d) number of medications; and (e) number of comorbid conditions. Each risk factor was assigned a specific score based on the logistic regression weights. For instance, for a wound (e.g., pressure ulcer, vascular ulcer), the patient received a score of 15 points. For each additional co-morbid condition, one point was added to the final score. Summing the scores for the factors generated a cumulative score. The optimal cut-off point was established based on the regression model performance statistics, indicating that patients with a score greater than 26 points are a high priority for the first nursing visit.

Sponsors & Collaborators

  • Visiting Nurse Service of New York

    collaborator OTHER

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Maxim Topaz, PhD · Associate Professor of Nursing at CUMC

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-04-01
Completion
2024-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04136951 on ClinicalTrials.gov